TriClip Japan Post-Approval Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TriClip Japan Post-Approval Study — Stella

Home/Tricuspid Regurgitation/

View on ClinicalTrials.gov

Recruiting

Back to Tricuspid Regurgitation trials

Trial locations(1 site)

Japan

National Cerebral & Cardiovascular Center Hospital, Suita, Osaka

Key details

Sponsor

Abbott Medical Devices

Enrollment target

~250 participants

Started

March 2026

Primary completion

February 2027

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.